What question did this study set out to answer?

To evaluate changes in health care coverage, antiretroviral therapy adherence, and sexually transmitted infection testing among people with diagnosed HIV before and after Medicaid expansion.

August 14, 2026AIDS CareOpen Access

Changes in health care coverage and sexually transmitted infection testing following expansion of health care coverage options among people with diagnosed HIV – Medical Monitoring Project, Virginia, 2015–2022

View Full Paper

Ask AI

Bookmark

Authors

KMKathleen A. McManus GSGarrett Shields KSKimberly Scott

Discussion

Member takes

Overview

Surveillance study reveals Medicaid expansion increased antiretroviral adherence and STI testing among people with HIV, indicating health coverage reduces care barriers.

Key Points

To evaluate changes in health care coverage, antiretroviral therapy adherence, and sexually transmitted infection testing among people with diagnosed HIV before and after Medicaid expansion.
Analyzed CDC Medical Monitoring Project surveillance data in Virginia from 2015 to 2022 (N = 1,169), comparing pre-expansion (2015–2018) and post-expansion (2020–2022) periods while excluding the 2019 transition year.
Calculated weighted percentages and assessed prevalence differences (PDs) with 95% confidence intervals using predicted marginal means.
Medicaid coverage rose from 18.9%–25.4% pre-expansion to 30.1%–33.9% post-expansion.
The percentage of participants missing ≥1 antiretroviral therapy dose in the past 30 days dropped from 37.6% pre-expansion to 29.9% post-expansion (PD: −7.7; 95% CI: −14.4 to −1.1).
Screening rates for gonorrhea, chlamydia, and syphilis in the past 12 months increased from 27.8% pre-expansion to 34.8% post-expansion (PD: 6.9; 95% CI: 0.5 to 13.3).

Cite This Study

McManus et al. (2026) studied this question.

synapsesocial.com/papers/6a7ec7bab70b84ec8b914554 https://doi.org/10.1080/09540121.2026.2697991

View Full Paper

Ask AI

Bookmark

August 14, 2026AIDS CareOpen Access

Changes in health care coverage and sexually transmitted infection testing following expansion of health care coverage options among people with diagnosed HIV – Medical Monitoring Project, Virginia, 2015–2022

View Full Paper

Ask AI

Bookmark

Authors

KMKathleen A. McManus GSGarrett Shields KSKimberly Scott

Discussion

Member takes

Overview

Surveillance study reveals Medicaid expansion increased antiretroviral adherence and STI testing among people with HIV, indicating health coverage reduces care barriers.

Key Points

To evaluate changes in health care coverage, antiretroviral therapy adherence, and sexually transmitted infection testing among people with diagnosed HIV before and after Medicaid expansion.
Analyzed CDC Medical Monitoring Project surveillance data in Virginia from 2015 to 2022 (N = 1,169), comparing pre-expansion (2015–2018) and post-expansion (2020–2022) periods while excluding the 2019 transition year.
Calculated weighted percentages and assessed prevalence differences (PDs) with 95% confidence intervals using predicted marginal means.
Medicaid coverage rose from 18.9%–25.4% pre-expansion to 30.1%–33.9% post-expansion.
The percentage of participants missing ≥1 antiretroviral therapy dose in the past 30 days dropped from 37.6% pre-expansion to 29.9% post-expansion (PD: −7.7; 95% CI: −14.4 to −1.1).
Screening rates for gonorrhea, chlamydia, and syphilis in the past 12 months increased from 27.8% pre-expansion to 34.8% post-expansion (PD: 6.9; 95% CI: 0.5 to 13.3).

Cite This Study

McManus et al. (2026) studied this question.

synapsesocial.com/papers/6a7ec7bab70b84ec8b914554 https://doi.org/10.1080/09540121.2026.2697991

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark